| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 22 | 2024 | 214 | 4.790 |
Why?
|
| Intestine, Small | 22 | 2023 | 299 | 4.000 |
Why?
|
| Capsule Endoscopy | 14 | 2023 | 33 | 3.260 |
Why?
|
| Endoscopy, Gastrointestinal | 17 | 2021 | 160 | 3.130 |
Why?
|
| Gastrointestinal Hemorrhage | 12 | 2023 | 237 | 2.060 |
Why?
|
| Diet, Gluten-Free | 8 | 2024 | 58 | 2.030 |
Why?
|
| Double-Balloon Enteroscopy | 5 | 2021 | 11 | 1.670 |
Why?
|
| Intestinal Diseases | 4 | 2021 | 79 | 1.560 |
Why?
|
| Parenteral Nutrition | 6 | 2024 | 63 | 1.520 |
Why?
|
| Nutrition Therapy | 3 | 2020 | 10 | 1.460 |
Why?
|
| Glutens | 8 | 2024 | 84 | 1.420 |
Why?
|
| Gastroenterologists | 3 | 2022 | 31 | 0.980 |
Why?
|
| Intestinal Neoplasms | 2 | 2020 | 67 | 0.970 |
Why?
|
| Intestinal Mucosa | 11 | 2020 | 805 | 0.960 |
Why?
|
| Short Bowel Syndrome | 4 | 2024 | 38 | 0.950 |
Why?
|
| Gastroenterology | 5 | 2022 | 146 | 0.930 |
Why?
|
| Doxycycline | 2 | 2013 | 28 | 0.870 |
Why?
|
| Gastric Mucosa | 3 | 2013 | 68 | 0.850 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2013 | 61 | 0.840 |
Why?
|
| Osteoporosis | 2 | 2019 | 122 | 0.830 |
Why?
|
| Nutritional Sciences | 2 | 2018 | 13 | 0.740 |
Why?
|
| Nutrition Assessment | 1 | 2020 | 20 | 0.720 |
Why?
|
| Carcinoid Tumor | 1 | 2020 | 45 | 0.700 |
Why?
|
| Bone Resorption | 1 | 2019 | 42 | 0.670 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2019 | 33 | 0.650 |
Why?
|
| Crohn Disease | 4 | 2020 | 763 | 0.650 |
Why?
|
| Adenoma | 1 | 2020 | 247 | 0.610 |
Why?
|
| Humans | 68 | 2024 | 89675 | 0.610 |
Why?
|
| Osteogenesis | 1 | 2019 | 258 | 0.580 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 790 | 0.580 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.570 |
Why?
|
| Enteral Nutrition | 3 | 2016 | 105 | 0.570 |
Why?
|
| Intensive Care Units | 1 | 2020 | 395 | 0.560 |
Why?
|
| Esophagitis | 2 | 2013 | 43 | 0.550 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 395 | 0.550 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 124 | 0.540 |
Why?
|
| Metabolic Syndrome | 1 | 2017 | 123 | 0.530 |
Why?
|
| Gastrointestinal Agents | 2 | 2020 | 172 | 0.530 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.500 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.500 |
Why?
|
| Peptides | 3 | 2020 | 649 | 0.480 |
Why?
|
| Adenocarcinoma | 3 | 2020 | 1201 | 0.480 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 263 | 0.440 |
Why?
|
| Transglutaminases | 3 | 2020 | 40 | 0.380 |
Why?
|
| Gastrointestinal Diseases | 4 | 2014 | 151 | 0.370 |
Why?
|
| Risk Factors | 9 | 2020 | 5517 | 0.360 |
Why?
|
| Jejunum | 1 | 2010 | 80 | 0.360 |
Why?
|
| Retrospective Studies | 12 | 2024 | 9091 | 0.350 |
Why?
|
| Jejunal Neoplasms | 1 | 2009 | 9 | 0.340 |
Why?
|
| Duodenal Neoplasms | 1 | 2009 | 19 | 0.340 |
Why?
|
| Ileal Neoplasms | 1 | 2009 | 9 | 0.340 |
Why?
|
| Intestinal Perforation | 1 | 2009 | 36 | 0.330 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 6842 | 0.330 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 70 | 0.330 |
Why?
|
| Female | 28 | 2024 | 46391 | 0.330 |
Why?
|
| Pancreatitis | 1 | 2009 | 86 | 0.320 |
Why?
|
| Endoscopes, Gastrointestinal | 2 | 2007 | 8 | 0.310 |
Why?
|
| Bone Density | 2 | 2019 | 209 | 0.310 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 265 | 0.300 |
Why?
|
| Gastrostomy | 3 | 2016 | 70 | 0.290 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 479 | 0.290 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2015 | 319 | 0.290 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 160 | 0.280 |
Why?
|
| Middle Aged | 20 | 2023 | 26086 | 0.270 |
Why?
|
| Adult | 20 | 2024 | 26708 | 0.260 |
Why?
|
| Catheterization | 4 | 2009 | 237 | 0.260 |
Why?
|
| Obesity | 3 | 2017 | 972 | 0.260 |
Why?
|
| Aged | 16 | 2024 | 19252 | 0.250 |
Why?
|
| Male | 24 | 2024 | 42581 | 0.250 |
Why?
|
| Interleukin-15 | 3 | 2015 | 73 | 0.240 |
Why?
|
| Fish Oils | 1 | 2024 | 14 | 0.240 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2024 | 16 | 0.240 |
Why?
|
| Inflammation | 3 | 2019 | 972 | 0.220 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2023 | 20 | 0.210 |
Why?
|
| Quality of Life | 2 | 2024 | 1675 | 0.200 |
Why?
|
| Diarrhea | 2 | 2014 | 182 | 0.200 |
Why?
|
| Liver Diseases | 1 | 2024 | 242 | 0.200 |
Why?
|
| Young Adult | 6 | 2020 | 6350 | 0.200 |
Why?
|
| HLA-DQ Antigens | 2 | 2019 | 51 | 0.190 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 364 | 0.190 |
Why?
|
| Calcium | 3 | 2019 | 1178 | 0.180 |
Why?
|
| Registries | 2 | 2020 | 791 | 0.180 |
Why?
|
| Sweden | 1 | 2020 | 40 | 0.180 |
Why?
|
| Deficiency Diseases | 1 | 1999 | 12 | 0.170 |
Why?
|
| Antigens | 2 | 2019 | 229 | 0.170 |
Why?
|
| Zinc | 1 | 1999 | 94 | 0.160 |
Why?
|
| Th1 Cells | 2 | 2017 | 166 | 0.160 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2019 | 69 | 0.160 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 21 | 0.160 |
Why?
|
| Osteoporotic Fractures | 1 | 2019 | 47 | 0.160 |
Why?
|
| Atrophy | 1 | 2018 | 121 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 105 | 0.150 |
Why?
|
| Gastrointestinal Hormones | 1 | 1997 | 6 | 0.150 |
Why?
|
| Reoviridae Infections | 1 | 2017 | 7 | 0.140 |
Why?
|
| Avena | 1 | 2017 | 19 | 0.140 |
Why?
|
| Fatal Outcome | 2 | 2016 | 298 | 0.140 |
Why?
|
| Vitamin D | 1 | 2019 | 269 | 0.140 |
Why?
|
| Intestinal Absorption | 3 | 2019 | 124 | 0.140 |
Why?
|
| Autoantibodies | 3 | 2020 | 268 | 0.140 |
Why?
|
| Vital Capacity | 1 | 2016 | 68 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2020 | 858 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2022 | 1049 | 0.130 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2016 | 27 | 0.130 |
Why?
|
| United States | 6 | 2015 | 7025 | 0.130 |
Why?
|
| Curriculum | 2 | 2018 | 568 | 0.130 |
Why?
|
| Leukotrienes | 1 | 2015 | 20 | 0.130 |
Why?
|
| Malnutrition | 1 | 2016 | 33 | 0.130 |
Why?
|
| Equipment Design | 3 | 2019 | 420 | 0.130 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2015 | 32 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2017 | 8276 | 0.130 |
Why?
|
| Attitude | 1 | 2016 | 130 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2019 | 540 | 0.130 |
Why?
|
| Overweight | 1 | 2016 | 119 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 187 | 0.120 |
Why?
|
| Adolescent | 6 | 2016 | 9290 | 0.120 |
Why?
|
| Cysteine | 1 | 2015 | 137 | 0.120 |
Why?
|
| Biopsy | 4 | 2019 | 1185 | 0.120 |
Why?
|
| Immunoglobulin A | 2 | 2020 | 83 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 776 | 0.120 |
Why?
|
| Cell Communication | 1 | 2015 | 200 | 0.120 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 167 | 0.110 |
Why?
|
| Abdominal Pain | 2 | 2013 | 138 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1728 | 0.110 |
Why?
|
| Mentors | 1 | 2014 | 88 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 2665 | 0.110 |
Why?
|
| Capsule Endoscopes | 1 | 2013 | 5 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2015 | 232 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 740 | 0.110 |
Why?
|
| Child | 4 | 2023 | 7202 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1994 | 502 | 0.110 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 68 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2020 | 2305 | 0.100 |
Why?
|
| Capillaries | 1 | 2013 | 90 | 0.100 |
Why?
|
| Necrosis | 1 | 2013 | 210 | 0.100 |
Why?
|
| Faculty, Medical | 1 | 2014 | 188 | 0.100 |
Why?
|
| Radiography, Abdominal | 1 | 2012 | 69 | 0.100 |
Why?
|
| Withholding Treatment | 1 | 2013 | 117 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2016 | 2286 | 0.100 |
Why?
|
| Cystic Fibrosis | 1 | 1993 | 115 | 0.100 |
Why?
|
| Carrier Proteins | 3 | 1996 | 681 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3461 | 0.100 |
Why?
|
| Stomach | 2 | 2010 | 111 | 0.100 |
Why?
|
| Time Factors | 1 | 2020 | 5344 | 0.090 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 94 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 2 | 2022 | 147 | 0.090 |
Why?
|
| Jejunostomy | 1 | 2010 | 14 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2015 | 689 | 0.090 |
Why?
|
| Sodium | 2 | 2000 | 331 | 0.090 |
Why?
|
| Angiography | 1 | 2011 | 208 | 0.090 |
Why?
|
| Remission Induction | 1 | 2013 | 741 | 0.090 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1990 | 39 | 0.090 |
Why?
|
| Ileostomy | 1 | 2010 | 29 | 0.090 |
Why?
|
| Consensus | 2 | 2022 | 360 | 0.090 |
Why?
|
| Tretinoin | 1 | 2011 | 128 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 170 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2012 | 712 | 0.090 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2009 | 1 | 0.080 |
Why?
|
| Intestinal Polyposis | 1 | 2009 | 2 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 714 | 0.080 |
Why?
|
| Malabsorption Syndromes | 1 | 2009 | 21 | 0.080 |
Why?
|
| Gastric Balloon | 1 | 2009 | 1 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2006 | 32 | 0.080 |
Why?
|
| Neoplasms | 1 | 2024 | 3080 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2020 | 1864 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2009 | 344 | 0.070 |
Why?
|
| GTP-Binding Proteins | 2 | 2020 | 145 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3671 | 0.070 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2006 | 26 | 0.070 |
Why?
|
| Intestinal Obstruction | 1 | 2007 | 89 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 845 | 0.070 |
Why?
|
| Duodenal Obstruction | 1 | 2006 | 4 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2019 | 950 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 1987 | 275 | 0.070 |
Why?
|
| Ileocecal Valve | 1 | 2005 | 5 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 2 | 2010 | 687 | 0.060 |
Why?
|
| Gastric Bypass | 1 | 2006 | 111 | 0.060 |
Why?
|
| Patient Selection | 1 | 2009 | 684 | 0.060 |
Why?
|
| Biological Transport | 2 | 1999 | 401 | 0.060 |
Why?
|
| Ileum | 2 | 2019 | 160 | 0.060 |
Why?
|
| Chicago | 1 | 2009 | 1432 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2006 | 277 | 0.060 |
Why?
|
| Palliative Care | 1 | 2006 | 264 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2006 | 451 | 0.050 |
Why?
|
| Stents | 1 | 2006 | 408 | 0.050 |
Why?
|
| Endoscopy | 1 | 2006 | 351 | 0.050 |
Why?
|
| Hepatitis B virus | 1 | 2003 | 45 | 0.050 |
Why?
|
| Virus Activation | 1 | 2003 | 42 | 0.050 |
Why?
|
| Hepatitis B | 1 | 2003 | 76 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2023 | 192 | 0.050 |
Why?
|
| Advisory Committees | 1 | 2022 | 90 | 0.050 |
Why?
|
| Immune Tolerance | 2 | 2017 | 339 | 0.050 |
Why?
|
| Animals | 9 | 2017 | 27445 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2003 | 154 | 0.050 |
Why?
|
| Hospitals | 1 | 2024 | 301 | 0.050 |
Why?
|
| Chlorides | 3 | 2000 | 103 | 0.050 |
Why?
|
| Diet | 2 | 2017 | 443 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 191 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2015 | 3398 | 0.050 |
Why?
|
| Ions | 1 | 2000 | 75 | 0.050 |
Why?
|
| Thymidine Phosphorylase | 1 | 2000 | 5 | 0.050 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2000 | 5 | 0.050 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2000 | 6 | 0.050 |
Why?
|
| Antibodies | 1 | 2022 | 354 | 0.050 |
Why?
|
| Saccharomyces | 1 | 2020 | 21 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 1577 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1665 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 1996 | 996 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2000 | 99 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2006 | 1527 | 0.040 |
Why?
|
| Biological Availability | 1 | 1999 | 92 | 0.040 |
Why?
|
| Duodenum | 1 | 2019 | 103 | 0.040 |
Why?
|
| Butyrophilins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Amiloride | 2 | 1990 | 36 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2019 | 16 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2000 | 520 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2000 | 130 | 0.040 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 1990 | 77 | 0.040 |
Why?
|
| Chickens | 2 | 1990 | 212 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 1996 | 1225 | 0.040 |
Why?
|
| Imidazoles | 2 | 1990 | 148 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2884 | 0.040 |
Why?
|
| Enterochromaffin Cells | 1 | 1997 | 2 | 0.040 |
Why?
|
| Natriuretic Peptides | 1 | 1997 | 6 | 0.040 |
Why?
|
| Chloride Channels | 2 | 1996 | 42 | 0.040 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 6 | 0.040 |
Why?
|
| Reoviridae | 1 | 2017 | 6 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 19 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 20 | 0.040 |
Why?
|
| Stomach Diseases | 1 | 1997 | 19 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 1997 | 293 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 3229 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2879 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 16 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2017 | 49 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1369 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2019 | 280 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 642 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 1997 | 72 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2017 | 115 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 394 | 0.030 |
Why?
|
| Lauric Acids | 1 | 1996 | 1 | 0.030 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1996 | 16 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 852 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1246 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2017 | 186 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2011 | 1134 | 0.030 |
Why?
|
| Receptors, Leukotriene | 1 | 2015 | 10 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 111 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2015 | 22 | 0.030 |
Why?
|
| Certification | 1 | 2016 | 61 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2016 | 125 | 0.030 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2015 | 33 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 108 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 3027 | 0.030 |
Why?
|
| Ion Channels | 2 | 1996 | 246 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2019 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 123 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 115 | 0.030 |
Why?
|
| Steatorrhea | 1 | 2014 | 2 | 0.030 |
Why?
|
| Pancreatic Function Tests | 1 | 2014 | 7 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 183 | 0.030 |
Why?
|
| Breath Tests | 1 | 2014 | 57 | 0.030 |
Why?
|
| Intestines | 1 | 2017 | 416 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 43 | 0.030 |
Why?
|
| Peptide Hormones | 1 | 2014 | 30 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 182 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 2014 | 67 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2014 | 312 | 0.030 |
Why?
|
| China | 1 | 2014 | 235 | 0.030 |
Why?
|
| Endocytosis | 1 | 1994 | 180 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1076 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 1535 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 460 | 0.030 |
Why?
|
| Research Design | 2 | 2006 | 601 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1771 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 774 | 0.030 |
Why?
|
| Mice | 3 | 2017 | 11807 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 728 | 0.030 |
Why?
|
| Operative Time | 1 | 2013 | 143 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2016 | 901 | 0.030 |
Why?
|
| Smoking | 1 | 2016 | 624 | 0.030 |
Why?
|
| Feces | 1 | 2014 | 331 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1997 | 2020 | 0.020 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 23 | 0.020 |
Why?
|
| Gliadin | 1 | 2011 | 17 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1990 | 13 | 0.020 |
Why?
|
| Jejunal Diseases | 1 | 2010 | 10 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 175 | 0.020 |
Why?
|
| Surgical Stapling | 1 | 2010 | 17 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2011 | 57 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2354 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 747 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 1990 | 60 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2011 | 111 | 0.020 |
Why?
|
| Isoquinolines | 1 | 1990 | 72 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2016 | 785 | 0.020 |
Why?
|
| Diverticulum | 1 | 2010 | 45 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 171 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2377 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2010 | 170 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 682 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 742 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1993 | 2063 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 2450 | 0.020 |
Why?
|
| Mutation | 1 | 2000 | 4165 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2641 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 306 | 0.020 |
Why?
|
| Nigericin | 1 | 1987 | 2 | 0.020 |
Why?
|
| Valinomycin | 1 | 1987 | 8 | 0.020 |
Why?
|
| Calcimycin | 1 | 1987 | 33 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 1987 | 17 | 0.020 |
Why?
|
| Buffers | 1 | 1987 | 26 | 0.020 |
Why?
|
| Alprostadil | 1 | 1987 | 25 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2011 | 452 | 0.020 |
Why?
|
| Glycine | 1 | 1987 | 95 | 0.020 |
Why?
|
| Butyrates | 1 | 1987 | 46 | 0.020 |
Why?
|
| Chelating Agents | 1 | 1987 | 69 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2006 | 18 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2006 | 123 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2016 | 1048 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 45 | 0.020 |
Why?
|
| North America | 1 | 2006 | 185 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 135 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 2006 | 133 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 2006 | 148 | 0.020 |
Why?
|
| Weight Loss | 1 | 2006 | 229 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 2006 | 184 | 0.010 |
Why?
|
| Lymphoma | 1 | 2006 | 265 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 236 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 3748 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 383 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 775 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 2331 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2003 | 142 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 102 | 0.010 |
Why?
|
| Blepharoptosis | 1 | 2000 | 11 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2000 | 135 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2000 | 79 | 0.010 |
Why?
|
| Ophthalmoplegia | 1 | 2000 | 11 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 2000 | 27 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2000 | 93 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2000 | 87 | 0.010 |
Why?
|
| Cell Line | 2 | 1996 | 2496 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1442 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2000 | 121 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2000 | 205 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 258 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 313 | 0.010 |
Why?
|
| Point Mutation | 1 | 2000 | 245 | 0.010 |
Why?
|
| Syndrome | 1 | 2000 | 449 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 951 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 299 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 453 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 4311 | 0.010 |
Why?
|
| Liver | 1 | 2003 | 1210 | 0.010 |
Why?
|
| Glucose | 1 | 2000 | 630 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1978 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 469 | 0.010 |
Why?
|
| Proteolipids | 1 | 1996 | 8 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1996 | 8 | 0.010 |
Why?
|
| Uncoupling Protein 1 | 1 | 1996 | 38 | 0.010 |
Why?
|
| Uridine Triphosphate | 1 | 1996 | 6 | 0.010 |
Why?
|
| Anions | 1 | 1996 | 31 | 0.010 |
Why?
|
| Photochemistry | 1 | 1996 | 38 | 0.010 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 1996 | 9 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1996 | 105 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1996 | 27 | 0.010 |
Why?
|
| Ion Transport | 1 | 1996 | 84 | 0.010 |
Why?
|
| Xenopus | 1 | 1996 | 126 | 0.010 |
Why?
|
| Adipose Tissue, Brown | 1 | 1996 | 86 | 0.010 |
Why?
|
| Protons | 1 | 1996 | 101 | 0.010 |
Why?
|
| Connexin 43 | 1 | 1996 | 94 | 0.010 |
Why?
|
| Cricetinae | 1 | 1996 | 558 | 0.010 |
Why?
|
| Radiography | 1 | 1997 | 809 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 1996 | 127 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1996 | 195 | 0.010 |
Why?
|
| Oocytes | 1 | 1996 | 219 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 316 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 1994 | 11 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1994 | 16 | 0.010 |
Why?
|
| Transferrin | 1 | 1994 | 19 | 0.010 |
Why?
|
| Colforsin | 1 | 1994 | 74 | 0.010 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1994 | 56 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 2368 | 0.010 |
Why?
|
| Iron | 1 | 1994 | 168 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 1120 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 432 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 1058 | 0.010 |
Why?
|
| Transfection | 1 | 1994 | 911 | 0.010 |
Why?
|
| Kinetics | 1 | 1994 | 1534 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1994 | 675 | 0.010 |
Why?
|